My name is Mohammed Aboukaoud. I grew up in Jaffa, a small multicultural community in Tel Aviv, Israel. I attended a multicultural English language school in Jaffa, where I spent most of my childhood. After graduating from the University of Tel Aviv with a degree in Medicine and earning a Doctorate in Clinical Pharmacy from the Hebrew University in Israel. I completed a one-year internship in Medicine at Rambam Healthcare Campus in Israel. Currently, I am a resident in psychiatry at Sheba Medical Center. I also enjoy my work as a clinical pharmacology lecturer to medical students. In my research, I've studied adverse events and drug interactions in anti-seizure medications. Recent work includes studying Lamotrigine cardiac events and Levetiracetam's interactions. I aim to address questions with practical applications, such as the FDA's cardiac arrest label on Lamotrigine. Additionally, I've explored the association of HLA-A*31:01 with higher frequency in certain communities in Israel, leading to hypersensitivity reactions with Carbamazepine, which has been included in the drug label by the Israeli Ministry. My clinical expertise and research interests are in psychopharmacology and its practical application in psychiatry, as well as the study of adverse events in all fields of pharmacology.